Adenosine and dopamine receptor antagonist binding in the rat ventral and dorsal striatum:: lack of changes after a neonatal bilateral lesion of the ventral hippocampus

被引:26
|
作者
Lillrank, SM
Lipska, BK
Weinberger, DR
Fredholm, BB
Fuxe, K
Ferré, S
机构
[1] Karolinska Inst, Dept Neurosci, S-17177 Stockholm, Sweden
[2] NIMH, Clin Brain Disorders Branch, Washington, DC 20032 USA
[3] Karolinska Inst, Dept Physiol & Pharmacol, S-17177 Stockholm, Sweden
关键词
D O I
10.1016/S0197-0186(99)00008-X
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
There is experimental evidence from radioligand binding experiments for the existence of strong antagonistic interactions between different subtypes of adenosine and dopamine receptors in the striatum, mainly between adenosine Al and dopamine D-1 and between adenosine A(2A) and dopamine D-2 receptors. These interactions seem to be more powerful in the ventral compared to the dorsal striatum, which might have some implications for the treatment of schizophrenia. The binding characteristics of different dopamine and adenosine receptor subtypes were analysed in the different striatal compartments (dorsolateral striatum and shell and core of the nucleus accumbens), by performing saturation experiments with the dopamine DI receptor antagonist [I-125]SCH-23982. the dopamine D2-3 receptor antagonist [H-3]raclopride, the adenosine Al receptor antagonist [H-3]DPCPX and the adenosine A(2A) receptor antagonist [H-3]SCH 58261. The experiments were also performed in rats with a neonatal bilateral lesion of the ventral hippocampus (VH), a possible animal model of schizophrenia. Both dopamine D2-3 and adenosine A(2A) receptors follow a similar pattern, with a lower density of receptors (40%) in the shell of the nucleus accumbens compared with the dorsolateral caudate-putamen. A lower density of adenosine A(1) receptors (20%) was also found in the shell of the nucleus accumbens compared with the caudate-putamen. On the other hand, dopamine D-1 receptors showed a similar density in the different striatal compartments. Therefore, differences in receptor densities cannot explain the stronger interactions between adenosine and dopamine receptors found in the ventral, compared to the dorsal striatum. No statistical differences in the binding characteristics of any of the different adenosine and dopamine receptor antagonists used were found between sham-operated and V-H-lesioned rats. (C) 1999 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:235 / 244
页数:10
相关论文
共 50 条
  • [21] Baseline synaptic dopamine concentration in human ventral and dorsal striatum:: A D2 receptor pet study
    Kegeles, LS
    Mawlawi, O
    Rodenhiser-Hill, J
    Martinez, D
    Broft, A
    Cooper, TB
    Van Heertum, RL
    Abi-Dargham, A
    Laruelle, M
    BIOLOGICAL PSYCHIATRY, 2002, 51 (08) : 168S - 168S
  • [22] Stimulation of the ventral subiculum of the hippocampus evokes glutamate receptor-mediated changes in dopamine efflux in the rat nucleus accumbens
    Blaha, CD
    Yang, CR
    Floresco, SB
    Barr, AM
    Phillips, AG
    EUROPEAN JOURNAL OF NEUROSCIENCE, 1997, 9 (05) : 902 - 911
  • [23] Changes in behavior and monoamine levels in microdialysate from dorsal striatum after 6-OHDA infusions into ventral striatum
    TranNguyen, LTL
    Castaneda, E
    MacBeth, T
    PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1996, 55 (01) : 141 - 150
  • [24] Evidence for the existence of dopamine d2-oxytocin receptor heteromers in the ventral and dorsal striatum with facilitatory receptor-receptor interactions
    Romero-Fernandez, W.
    Borroto-Escuela, D. O.
    Agnati, L. F.
    Fuxe, K.
    MOLECULAR PSYCHIATRY, 2013, 18 (08) : 849 - 850
  • [25] The 5-HT1A receptor modulates motor/exploratory activity, object recognition and DAT binding in the dorsal and ventral striatum of the rat
    Nikolaus, S.
    Beu, M.
    Henke, J.
    Antke, C.
    Fazari, B.
    Mamlins, E.
    Giesel, F. L.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (SUPPL 1) : S256 - S256
  • [26] The neonatal ventral hippocampal lesion model of schizophrenia: effects on dopamine and GABA mRNA markers in the rat midbrain
    Lipska, BK
    Lerman, DN
    Khaing, ZZ
    Weinberger, DR
    EUROPEAN JOURNAL OF NEUROSCIENCE, 2003, 18 (11) : 3097 - 3104
  • [27] Chronic administration of the neurotrophic agent cerebrolysin ameliorates the behavioral and morphological changes induced by neonatal ventral hippocampus lesion in a rat model of schizophrenia
    Antonio Vazquez-Roque, Ruben
    Ramos, Brenda
    Tecuatl, Carolina
    Juarez, Ismael
    Adame, Anthony
    de la Cruz, Fidel
    Zamudio, Sergio
    Mena, Raul
    Rockenstein, Edward
    Masliah, Eliezer
    Flores, Gonzalo
    JOURNAL OF NEUROSCIENCE RESEARCH, 2012, 90 (01) : 288 - 306
  • [28] COMPARISON OF THE EFFECT OF PROLACTIN ON DOPAMINE RELEASE FROM THE RAT DORSAL AND VENTRAL STRIATUM AND FROM THE MEDIOBASAL HYPOTHALAMUS SUPERFUSED INVITRO
    CHEN, JC
    RAMIREZ, VD
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1988, 149 (1-2) : 1 - 8
  • [29] High doses of amphetamine augment, rather than disrupt, exocytotic dopamine release in the dorsal and ventral striatum of the anesthetized rat
    Ramsson, Eric S.
    Howard, Christopher D.
    Covey, Dan P.
    Garris, Paul A.
    JOURNAL OF NEUROCHEMISTRY, 2011, 119 (06) : 1162 - 1172
  • [30] Nicotinic acetylcholine receptor regulation of striatal dopamine transmission: The different requirement for diverse subtypes in ventral versus dorsal striatum
    Exley, Richard
    McIntosh, J. Michael
    Marks, Michael
    Maskos, Uwe
    Cragg, Stephanie J.
    BIOCHEMICAL PHARMACOLOGY, 2013, 86 (08) : 1228 - 1229